Report Detail
Global (United States, European Union and China) Valsartan Drug Market Research Report 2019-2025
- RnM3713061 |
- 30 August, 2019 |
- Global |
- 129 Pages |
- QYResearch |
- Pharma & Healthcare
Valsartan (trade name Diovan, Novartis International AG) is mainly used for treatment of high blood pressure, congestive heart failure, and to increase the chances of living longer after a heart attack. It is an angiotensin II receptor antagonist (commonly called an ARB, or angiotensin receptor blocker), that is selective for the type I (AT1) angiotensin receptor.
In 2019, the market size of Valsartan Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Valsartan Drug.
This report studies the global market size of Valsartan Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Valsartan Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Novartis
Sun Pharmaceutical
Teva
Mylan
Alembic Pharmaceuticals
Lupin
Aurobindo Pharma
Macleods Pharmaceuticals
HETERO
Torrent Pharmaceuticals
Huaren Pharmaceutical
Jubilant Pharma
Amneal Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Square Pharmaceuticals
Unichem Laboratories
Market Segment by Product Type
40 mg Tablets
80 mg Tablets
160 mg Tablets
320 mg Tablets
Market Segment by Application
Hypertension
Heart Failure
Heart Attack
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Valsartan Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Valsartan Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Valsartan Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Valsartan Drug Market Size Growth Rate by Type (2019-2025)
- 1.3.2 40 mg Tablets
- 1.3.3 80 mg Tablets
- 1.3.4 160 mg Tablets
- 1.3.5 320 mg Tablets
- 1.4 Market Segment by Application
- 1.4.1 Global Valsartan Drug Market Share by Application (2019-2025)
- 1.4.2 Hypertension
- 1.4.3 Heart Failure
- 1.4.4 Heart Attack
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Valsartan Drug Market Size
- 2.1.1 Global Valsartan Drug Revenue 2014-2025
- 2.1.2 Global Valsartan Drug Sales 2014-2025
- 2.2 Valsartan Drug Growth Rate by Regions
- 2.2.1 Global Valsartan Drug Sales by Regions 2014-2019
- 2.2.2 Global Valsartan Drug Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Valsartan Drug Sales by Manufacturers
- 3.1.1 Valsartan Drug Sales by Manufacturers 2014-2019
- 3.1.2 Valsartan Drug Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Valsartan Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Valsartan Drug Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Valsartan Drug Market Concentration Ratio (CR5 and HHI)
- 3.3 Valsartan Drug Price by Manufacturers
- 3.4 Key Manufacturers Valsartan Drug Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Valsartan Drug Market
- 3.6 Key Manufacturers Valsartan Drug Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 40 mg Tablets Sales and Revenue (2014-2019)
- 4.1.2 80 mg Tablets Sales and Revenue (2014-2019)
- 4.1.3 160 mg Tablets Sales and Revenue (2014-2019)
- 4.1.4 320 mg Tablets Sales and Revenue (2014-2019)
- 4.2 Global Valsartan Drug Sales Market Share by Type
- 4.3 Global Valsartan Drug Revenue Market Share by Type
- 4.4 Valsartan Drug Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Valsartan Drug Sales by Application
6 United States
- 6.1 United States Valsartan Drug Breakdown Data by Company
- 6.2 United States Valsartan Drug Breakdown Data by Type
- 6.3 United States Valsartan Drug Breakdown Data by Application
7 European Union
- 7.1 European Union Valsartan Drug Breakdown Data by Company
- 7.2 European Union Valsartan Drug Breakdown Data by Type
- 7.3 European Union Valsartan Drug Breakdown Data by Application
8 China
- 8.1 China Valsartan Drug Breakdown Data by Company
- 8.2 China Valsartan Drug Breakdown Data by Type
- 8.3 China Valsartan Drug Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Valsartan Drug Breakdown Data by Company
- 9.2 Rest of World Valsartan Drug Breakdown Data by Type
- 9.3 Rest of World Valsartan Drug Breakdown Data by Application
- 9.4 Rest of World Valsartan Drug Breakdown Data by Countries
- 9.4.1 Rest of World Valsartan Drug Sales by Countries
- 9.4.2 Rest of World Valsartan Drug Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Novartis
- 10.1.1 Novartis Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Valsartan Drug
- 10.1.4 Valsartan Drug Product Introduction
- 10.1.5 Novartis Recent Development
- 10.2 Sun Pharmaceutical
- 10.2.1 Sun Pharmaceutical Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Valsartan Drug
- 10.2.4 Valsartan Drug Product Introduction
- 10.2.5 Sun Pharmaceutical Recent Development
- 10.3 Teva
- 10.3.1 Teva Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Valsartan Drug
- 10.3.4 Valsartan Drug Product Introduction
- 10.3.5 Teva Recent Development
- 10.4 Mylan
- 10.4.1 Mylan Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Valsartan Drug
- 10.4.4 Valsartan Drug Product Introduction
- 10.4.5 Mylan Recent Development
- 10.5 Alembic Pharmaceuticals
- 10.5.1 Alembic Pharmaceuticals Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Valsartan Drug
- 10.5.4 Valsartan Drug Product Introduction
- 10.5.5 Alembic Pharmaceuticals Recent Development
- 10.6 Lupin
- 10.6.1 Lupin Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Valsartan Drug
- 10.6.4 Valsartan Drug Product Introduction
- 10.6.5 Lupin Recent Development
- 10.7 Aurobindo Pharma
- 10.7.1 Aurobindo Pharma Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Valsartan Drug
- 10.7.4 Valsartan Drug Product Introduction
- 10.7.5 Aurobindo Pharma Recent Development
- 10.8 Macleods Pharmaceuticals
- 10.8.1 Macleods Pharmaceuticals Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Valsartan Drug
- 10.8.4 Valsartan Drug Product Introduction
- 10.8.5 Macleods Pharmaceuticals Recent Development
- 10.9 HETERO
- 10.9.1 HETERO Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Valsartan Drug
- 10.9.4 Valsartan Drug Product Introduction
- 10.9.5 HETERO Recent Development
- 10.10 Torrent Pharmaceuticals
- 10.10.1 Torrent Pharmaceuticals Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Valsartan Drug
- 10.10.4 Valsartan Drug Product Introduction
- 10.10.5 Torrent Pharmaceuticals Recent Development
- 10.11 Huaren Pharmaceutical
- 10.12 Jubilant Pharma
- 10.13 Amneal Pharmaceuticals
- 10.14 Zhejiang Huahai Pharmaceutical
- 10.15 Square Pharmaceuticals
- 10.16 Unichem Laboratories
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Valsartan Drug Sales Channels
- 11.2.2 Valsartan Drug Distributors
- 11.3 Valsartan Drug Customers
12 Market Forecast
- 12.1 Global Valsartan Drug Sales and Revenue Forecast 2019-2025
- 12.2 Global Valsartan Drug Sales Forecast by Type
- 12.3 Global Valsartan Drug Sales Forecast by Application
- 12.4 Valsartan Drug Forecast by Regions
- 12.4.1 Global Valsartan Drug Sales Forecast by Regions 2019-2025
- 12.4.2 Global Valsartan Drug Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Valsartan Drug. Industry analysis & Market Report on Valsartan Drug is a syndicated market report, published as Global (United States, European Union and China) Valsartan Drug Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Valsartan Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
